Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03209973
Brief Title: A Study of Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma

First Submitted : May 25, 2017
First Submitted that Met QC Criteria : July 4, 2017
First Posted : July 6, 2017

Results First Submitted : August 12, 2020
Results First Submitted that Met QC Criteria : September 17, 2020
Results First Posted : October 12, 2020

Last Update Submitted that Met QC Criteria : February 22, 2021
Last Update Posted : March 16, 2021